Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [31] Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives
    Pirker, Robert
    Filipits, Martin
    CLINICAL LUNG CANCER, 2019, 20 (01) : 1 - 6
  • [32] Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection
    Liu, Weishuai
    Shao, Yuejuan
    Guan, Bingqing
    Hao, Jianlei
    Cheng, Xianjiang
    Ji, Kai
    Wang, Kun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11268 - 11277
  • [33] Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer
    Kensuke Kataoka
    Ryujiro Suzuki
    Hiroyuki Taniguchi
    Yasunobu Noda
    Joe Shindoh
    Syuichi Matsumoto
    Yoshiaki Watanabe
    Kousuke Honda
    Kiyoshi Suzuki
    Kenji Baba
    Kazuyoshi Imaizumi
    Hiroaki Kume
    Yoshinori Hasegawa
    Kenzo Takagi
    Lung, 2006, 184 : 133 - 139
  • [34] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
  • [35] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Lin Run Wang
    Ming Zhu Huang
    Guo Bing Zhang
    Nong Xu
    Xiu Hua Wu
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 601 - 607
  • [36] Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer
    Funai, Kazuhito
    Takamochi, Kazuya
    Itaya, Toru
    Mochizuki, Takahiro
    Nakamura, Toru
    Toyoda, Futoru
    Yong-Il, Kim
    Sasaki, Kazuyoshi
    Momiki, Shigeru
    Takahashi, Tsuyoshi
    Neyatani, Hiroshi
    Suzuki, Kazuya
    LUNG CANCER, 2010, 68 (01) : 78 - 83
  • [37] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
  • [38] Phase I/II trial of docetaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Shoji A.
    Ogura T.
    Suzuki K.
    Takahashi H.
    Takahashi K.
    Yoshiike Y.
    Watanuki Y.
    Nishiyama H.
    Toda M.
    Odagiri S.
    International Journal of Clinical Oncology, 2000, 5 (5) : 323 - 327
  • [39] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [40] A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer
    Tomizawa, Yoshio
    Ishihara, Shin-ichi
    Iijima, Hironobu
    Imai, Hisao
    Sato, Koji
    Yatomi, Masakiyo
    Iwasaki, Yasuki
    Yamada, Hidenori
    Kobayashi, Go
    Ishida, Emi
    Inoue, Teruki
    Aoki, Haruka
    Watanabe, Satoru
    Kawashima, Osamu
    Mori, Masatomo
    Saito, Ryusei
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (05): : 498 - 502
12345